|
|
|
| Therapeutic effect and safety of Triptorelin Acetate in the treatment of central precocious puberty in women |
| WEI Miao-miao |
| Department of Pediatrics,Huizhou First People′s Hospital,Guangdong Province,Huizhou 516000,China |
|
|
|
|
Abstract Objective To explore and analyze the clinical efficacy and safety of Triptorelin Acetate in the treatment of central precocious puberty in women.Methods A total of 90 girls with central precocious puberty treated in our outpatient clinics and inpatient wards from October 2014 to August 2016 were selected as the study subjects.According to different treatment methods,the patients were evenly divided into two groups,45 cases in each group.In experimental group,patients were treated with Triptorelin Acetate,one year was for a course of treatment.In control group,patients were not provided with any intervention.After one course of treatment,the height,weight,body mass index(BMI)and predicted height before and after treatment were observed,recorded and calculated.The hormone levels such as serum estradiol(E2),follicle stimulating hormone(FSH)and luteinising hormone(LH)before and after therapy were determined in order to evaluate the therapeutic efficacy.ResultsAfter one course of treatment,the height,weight,predicted height,bone age of the two groups were significantly higher than before treatment,the differences were statistically significant(P＜0.05).The the height,weight and predicted height in the experimental group were much higher than those of the control group,while the bone age of the experimental group were significantly lower compared with those in the control group,the differences were statistically significant(P＜0.05).The serum levels of E2,FSH and LH after therapy in the two groups were significantly lower than those before treatment with statistical significance (P＜0.05).The levels of E2,FSH and LH in the experimental group were significantly lower than in the control group,the differences were statistically significant(P＜0.05).The incidence of adverse reactions in the experimental group was significantly lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion The effect of Triptorelin Acetate in the treatment of female central precocious puberty is good and worthy of clinical promotion.
|
|
|
|
|
|
| [1] |
章铭，沈文霞.醋酸曲普瑞林与醋酸亮丙瑞林缓释微球治疗特发性中枢性早熟临床效果比较[J].药物流行病学杂志，2017，26（9）：597-600.
|
| [2] |
陈赛兰，张丹丹，高琴，等.醋酸曲普瑞林在治疗女性中枢性性早熟中的临床疗效与安全性探讨[J].中国性科学，2017，26（5）：43-46.
|
| [3] |
杨坤.曲普瑞林治疗女童特发性中枢性性早熟临床效果观察[D].石家庄：河北医科大学，2017.
|
| [4] |
许文萍，余亮，谢磊.醋酸曲普瑞林治疗特发性中枢性性早熟女童的短期疗效评估[J].贵州医药，2016，40（5）：495-497.
|
| [5] |
中华医学会儿科学分会内分泌遗传代谢学组.中枢性（真性）性早熟诊治指南[J].中华儿科杂志，2007，45（6）：462-467.
|
| [6] |
中华人民共和国卫生部疾病预防控制局.中国学龄儿童青少年超重和肥胖预防与控制指南[S].北京：人民卫生出版社，2008.
|
| [7] |
中华医学会内分泌遗传代谢组.对中枢性（真性）性早熟诊断和治疗的建议[S].中华儿科杂志，2003，41（4）：272.
|
| [8] |
Ahmet A，Catll Gonül，Ayhan A，et al.Effect of gonadotropinreleasing hormone agonist therapy on body mass index and growth in girls with idiopathic central precocious puberty[J].Indian J Endocrinol Metab，2015，19（2）：267-271.
|
| [8] |
陈秋莉，马华梅，李燕虹，等.促性腺激素释放激素类似物改善中枢性性早熟和快速进展型早发育女孩成年身高：单中心15年102例病例追踪研究[J].中华内分泌代谢杂志，2013，29（3）：236-240.
|
| [9] |
张颖，张洁，倪金凤，等.醋酸曲普瑞林与醋酸甲地孕酮片治疗特发性中枢性早熟临床疗效比较[J].现代生物医学进展，2016，16（22）：4352-4354.
|
| [10] |
王莉菁，蒋键波，方兴.醋酸曲普瑞林治疗特发性中枢性早熟临床效果观察[J].中国性科学，2015，24（10）：14-16.
|
| [11] |
Giabicani E，Lemaire P，Brauner R.Models for predicting the adultheight and age at first menstruation of girls with idiopathic centralprecociouspuberty[J].PLoS One，2015，10（3）：e0120588.
|
| [12] |
柯江维，段荣.性早熟和性早熟危险因素研究进展[J].实验与检验医学，2012，10（3）：158-162.
|
| [13] |
颜纯，王慕逖.小儿内分泌学[M].2版.北京：人民卫生出版社，2006：79.
|
| [14] |
刘丽君，刘智慧，马雪年，等.促性腺激素释放激素类似物治疗特发性中枢性性早熟女童疗效观察[J].河北医药，2011，33（21）：3277-3278.
|
| [15] |
章昌敏.超声监测子宫卵巢形态学变化在特发性中枢性性早熟女孩治疗中的应用分析[J].中国实用医刊，2016，43（5）：72-73.
|
|
|
|
